Literature DB >> 7406618

Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients.

V C Gandhi, H M Humayun, T S Ing, J T Daugirdas, V R Jablokow, S Iwatsuki, W P Geis, J E Hano.   

Abstract

Five patients receiving maintenance peritoneal dialysis (duration, three months to four years) required surgical exploration of the abdomen for various reasons. Four had a prior history of bacterial peritonitis, and four of aseptic peritonitis. At laparotomy, the peritoneal membrane was found to be markedly thickened and sclerotic in all patients, and loops of bowel were bound together in a dense, opaque casing. On microscopic examination, an increase in fibroconnective tissue in the peritoneum was observed.

Entities:  

Mesh:

Year:  1980        PMID: 7406618

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  50 in total

1.  Sclerosing peritonitis after kidney transplantation: a not-so-silky cocoon.

Authors:  Ellen H Morrow; Amy E Gallo; Marc L Melcher
Journal:  Dig Dis Sci       Date:  2010-11-10       Impact factor: 3.199

2.  Chronic abdominal pain in a patient on chronic peritoneal dialysis: answer.

Authors:  Olivera Marsenic; Bernard Kaplan; Kevin E C Meyers
Journal:  Pediatr Nephrol       Date:  2008-07-09       Impact factor: 3.714

3.  Classification of encapsulating peritoneal sclerosis is important, but must encapsulate the entire spectrum of the disease.

Authors:  Christopher J E Watson; Andrew J Butler; J Andrew Bradley
Journal:  Perit Dial Int       Date:  2013 Sep-Oct       Impact factor: 1.756

Review 4.  Encapsulating peritoneal sclerosis in children.

Authors:  Constantinos J Stefanidis; Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2013-11-21       Impact factor: 3.714

5.  Restoration of peritoneal integrity after withdrawal of peritoneal dialysis: characteristic features of the patients at risk of encapsulating peritoneal sclerosis.

Authors:  Yasushi Otsuka; Masaaki Nakayama; Masato Ikeda; Ali M Sherif; Keitaro Yokoyama; Hiroyasu Yamamoto; Yoshindo Kawaguchi
Journal:  Clin Exp Nephrol       Date:  2005-12       Impact factor: 2.801

6.  Sclerosing encapsulating peritonitis.

Authors:  M Wanic-Kossowska; A Grzegorzewska; H Płotast
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

7.  22-Oxacalcitriol prevents progression of peritoneal fibrosis in a mouse model.

Authors:  Misaki Hirose; Tomoya Nishino; Yoko Obata; Masayuki Nakazawa; Yuka Nakazawa; Akira Furusu; Katsushige Abe; Masanobu Miyazaki; Takehiko Koji; Shigeru Kohno
Journal:  Perit Dial Int       Date:  2012-10-02       Impact factor: 1.756

8.  Can EPS development be avoided with early interventions? The potential role of tamoxifen--a single-center study.

Authors:  Erika De Sousa-Amorim; Gloria Del Peso; M Auxiliadora Bajo; Laura Alvarez; Marta Ossorio; Fernando Gil; Teresa Bellon; Rafael Selgas
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

9.  SAHA Suppresses Peritoneal Fibrosis in Mice.

Authors:  Kumiko Io; Tomoya Nishino; Yoko Obata; Mineaki Kitamura; Takehiko Koji; Shigeru Kohno
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

10.  Assessing the validity of an abdominal CT scoring system in the diagnosis of encapsulating peritoneal sclerosis.

Authors:  Ruth M Tarzi; Adrian Lim; Steven Moser; Sohail Ahmad; Abraham George; Gowrie Balasubramaniam; Elaine J Clutterbuck; Wladyslaw Gedroyc; Edwina A Brown
Journal:  Clin J Am Soc Nephrol       Date:  2008-07-30       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.